Roshan M. Kumar, PhD

Executive Director, Head of Research
HiFiBiO Therapeutics

Poster(s):

• W118 - HFB202501, a Novel Anti-PD-1 Antibody with Enhanced Effector Functions for Precision Depletion of Pathogenic T Cells in Autoimmune Diseases
  Wednesday, June 25, 2025

  7:30am - 7:30pm East Coast USA Time

• Th193 - Application of HiFiBiO Drug Intelligence Science (DIS®) Translational Platform to Guide the Clinical Development of HFB200604, a Phase I BTLA Agonist Monoclonal Antibody
  Thursday, June 26, 2025

  7:30am - 7:45pm East Coast USA Time

• Tu113 - A Novel Biparatopic KLRG1 Antibody Selectively Depletes Effector Memory CD8+ T Cells for Autoimmune Disease Treatment
  Tuesday, June 24, 2025

  6:00pm - 7:30pm East Coast USA Time